RU97111543A - METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION - Google Patents

METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION

Info

Publication number
RU97111543A
RU97111543A RU97111543/14A RU97111543A RU97111543A RU 97111543 A RU97111543 A RU 97111543A RU 97111543/14 A RU97111543/14 A RU 97111543/14A RU 97111543 A RU97111543 A RU 97111543A RU 97111543 A RU97111543 A RU 97111543A
Authority
RU
Russia
Prior art keywords
viral infection
neurological disorders
treating neurological
chronic form
disorders related
Prior art date
Application number
RU97111543/14A
Other languages
Russian (ru)
Other versions
RU2141824C1 (en
Inventor
Е.М. Васильева
Л.С. Лозовская
Т.А. Шор
Т.А. Матковская
Е.Г. Сологубов
М.И. Баканов
Original Assignee
Е.М. Васильева
Л.С. Лозовская
Т.А. Шор
Т.А. Матковская
Е.Г. Сологубов
М.И. Баканов
Filing date
Publication date
Application filed by Е.М. Васильева, Л.С. Лозовская, Т.А. Шор, Т.А. Матковская, Е.Г. Сологубов, М.И. Баканов filed Critical Е.М. Васильева
Priority to RU97111543A priority Critical patent/RU2141824C1/en
Priority claimed from RU97111543A external-priority patent/RU2141824C1/en
Publication of RU97111543A publication Critical patent/RU97111543A/en
Application granted granted Critical
Publication of RU2141824C1 publication Critical patent/RU2141824C1/en

Links

Claims (1)

Способ лечения неврологических нарушений, связанных с хронической формой врожденной вирусной инфекции с применением лекарственного средства, отличающийся тем, что в качестве наружного лечебного средства используют состав, содержащий 1-2 мас.% тринатриевой соли фосфонмуравьиной кислоты, 0,25-2 мас. % ксидифона и основу, включающую соевое масло, который наносят 1 раз в сутки при 1-1,5 месячном курсе лечения.A method of treating neurological disorders associated with a chronic form of a congenital viral infection using a drug, characterized in that as an external therapeutic agent, a composition containing 1-2 wt.% Trisodium salt of phosphonoformic acid, 0.25-2 wt. % xidiphone and a base including soybean oil, which is applied 1 time per day for 1-1.5 months of treatment.
RU97111543A 1997-07-02 1997-07-02 Method of treating neurological disturbances associated with chronic form of innate viral infection RU2141824C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97111543A RU2141824C1 (en) 1997-07-02 1997-07-02 Method of treating neurological disturbances associated with chronic form of innate viral infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97111543A RU2141824C1 (en) 1997-07-02 1997-07-02 Method of treating neurological disturbances associated with chronic form of innate viral infection

Publications (2)

Publication Number Publication Date
RU97111543A true RU97111543A (en) 1999-06-10
RU2141824C1 RU2141824C1 (en) 1999-11-27

Family

ID=20195057

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97111543A RU2141824C1 (en) 1997-07-02 1997-07-02 Method of treating neurological disturbances associated with chronic form of innate viral infection

Country Status (1)

Country Link
RU (1) RU2141824C1 (en)

Similar Documents

Publication Publication Date Title
ATE203019T1 (en) NEW (R)-5-CARBAMOYL-8-FLUORINE-3-N,N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANES
DE60126980D1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC ILLNESSES
ATE73331T1 (en) USE OF TETRAHYDROBIOPTERINS TO MANUFACTURE A MEDICATION FOR THE TREATMENT OF CHILDREN'S AUTISM.
DE69909818D1 (en) PYRAZOLOPYIMIDINONE DERIVATIVES FOR TREATING IMPOTENCE
NZ512526A (en) 4-sulfonamido-6-sulfamidoalkoxypyrimidine derivatives, pharmaceuticals thereof, and their use for the treatment of disorders associated with a role of endothelin.
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
ATE439833T1 (en) PHARMACEUTICAL PREPARATION CONTAINING A CATECHINE, ASCORBIC ACID, PROLINE AND LYSINE FOR THE TREATMENT OF NEOPLASTIC DISEASES
DE60220055D1 (en) 4- (4-METHOXYBENZYL) -N '- (5-NITRO-1,3-THIAZOLE-2-YL) UREA AND ITS USE IN THE TREATMENT OF GLYCOGENSYNTHASEKINASE-3 (GSK3) ASSOCIATED SUFFERING
ATE409028T1 (en) MEDICATIONS FOR THE TREATMENT OF NERVE DISEASES
ATE225171T1 (en) AMINO ACID DERIVATIVES FOR THE TREATMENT OF STROKE
RU94040886A (en) Use of melatonine derivatives for sleep disturbance treatment, pharmaceutical composition
ATE321045T1 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN
NO970573D0 (en) Yliden compounds and their preparation
DE60108130D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
RU97111543A (en) METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION
DE69626916D1 (en) Sertraline used to treat post-myocardial infarction patients
FI894119A0 (en) Process for the preparation of the trisodium salt of isoserine N, N-diacetic acid
HUT62303A (en) Process for producing n-substituted aminomethane diphosphonic acids and pharmaceutical compositions comprising same as active ingredient
MX9600165A (en) 3-alkoxycarbonylthiadiazinonas, process for the preparation thereof and pharmaceutical compositions containing them.
ATE276231T1 (en) NITROXY DERIVATIVES OF (R) AND (S)-CARNITINE
DE60121978D1 (en) 7-CHLORO-4-HYDROXY-2- (2-PYRIDYLETHYL) -1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BOCHINOLINE-1,10-DIONE AND ITS USE FOR THE TREATMENT OF PAIN
DE69910706D1 (en) Drug used to treat glaucoma and ischemic retinopathy
DE69827706D1 (en) 5- (Heteroaryl) alkyl) -3-oxo-pyrido (1,2-a) benzimidazole-4-carboxamide (PBI) derivatives for the treatment of disorders of the central nervous system
RU99101827A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES
RU94013606A (en) Hemostimulator